Click to view your profile
Click to search for condition or expert
Click to open main menu
Embryonal Tumor with Multilayered Rosettes Latest Advances
Find the Latest Research About Embryonal Tumor with Multilayered Rosettes
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/20/2023
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 242 publications
See more filters
The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next?
Condition:
Neuroendocrine Tumors (NETs)
Journal:
Frontiers in endocrinology
Treatment Used:
Peptide Receptor Radionuclide Therapy (PRRT) and Lu-177
Published:
November 17, 2022
VIEW PUBLICATION
Patients with non-functional metastatic G2 pancreatic neuroendocrine tumor benefit from palliative surgery: A 20-year single-center retrospective analysis.
Condition:
Non-Functional Metastatic G2 Pancreatic Neuroendocrine Tumor (pNET)
Journal:
Journal of neuroendocrinology
Treatment Used:
Palliative Surgery
Number of Patients:
69
Published:
November 14, 2022
VIEW PUBLICATION
Capecitabine and temozolomide for metastatic intermediate to high-grade pancreatic neuroendocrine neoplasm: a single center experience.
Condition:
Metastatic Intermediate to High-Grade Pancreatic Neuroendocrine Neoplasm (pNEC)
Journal:
The Korean journal of internal medicine
Treatment Used:
Capecitabine and Temozolomide (CAPTEM)
Number of Patients:
12
Published:
November 14, 2022
VIEW PUBLICATION
A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161.
Condition:
Advanced Pancreatic Neuroendocrine Tumors (PNETs)
Journal:
Investigational new drugs
Treatment Used:
Sapanisertib
Number of Patients:
13
Published:
October 20, 2022
VIEW PUBLICATION
Teserpaturev/G47Δ: First Approval.
Condition:
Malignant Glioma
Journal:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Treatment Used:
Teserpaturev/G47Δ
Number of Patients:
0
Published:
September 13, 2022
VIEW PUBLICATION
Pediatric Abdominal Malignancies and Intravascular Extension: Contemporary Single-Center Experience.
Condition:
Pediatric Abdominal Malignancies and Intravascular Extension
Journal:
The Journal of surgical research
Treatment Used:
Various Treatments
Number of Patients:
14
Published:
August 29, 2022
VIEW PUBLICATION
Adult medulloblastoma: a case report.
Condition:
Adult Medulloblastoma
Journal:
Journal of medical case reports
Treatment Used:
Surgery, Radiotherapy, and Chemotherapy
Number of Patients:
1
Published:
August 24, 2022
VIEW PUBLICATION
A rare radiotherapy-sensitive primitive neuroectodermal tumor with APC gene amplification in an adult: a case report and literature review.
Condition:
Primitive Neuroectodermal Tumor (PNET) of Lung
Journal:
The Journal of international medical research
Treatment Used:
Chemotherapy and Radiotherapy
Number of Patients:
1
Published:
August 19, 2022
VIEW PUBLICATION
Meta of classical chemotherapy compared with high-dose chemotherapy and autologous stem cell rescue in newly diagnosed medulloblastoma after radiotherapy.
Condition:
Medulloblastoma
Journal:
Medicine
Treatment Used:
High-Dose Chemotherapy Combined with Autologous Stem Cell Rescue (HDCT + ASCR)
Number of Patients:
2477
Published:
July 29, 2022
VIEW PUBLICATION
Rotational Occipital Scalp Flap for Occipital Pressure Ulcer.
Condition:
Occipital Pressure Ulcer
Journal:
Neurology India
Treatment Used:
Rotational Occipital Scalp Flap
Number of Patients:
1
Published:
July 22, 2022
VIEW PUBLICATION
Minimally Invasive vs Open Pancreatectomy for Pancreatic Neuroendocrine Tumors: Multi-Institutional 10-Year Experience of 1,023 Patients.
Condition:
Pancreatic Neuroendocrine Tumors (PNETs)
Journal:
Journal of the American College of Surgeons
Treatment Used:
Minimally Invasive Pancreatectomy
Number of Patients:
1023
Published:
July 15, 2022
VIEW PUBLICATION
A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma.
Condition:
Pediatric Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma.
Journal:
Clinical cancer research : an official journal of the American Association for Cancer Research
Treatment Used:
TB-403
Number of Patients:
15
Published:
July 14, 2022
VIEW PUBLICATION
Showing 1-12 of 242
Next
Last Updated: 01/20/2023